The Patent Finder
US

Crystalline solvate forms of a pharmaceutical

US 9,850,271 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 3, 2029 · High confidence

Filed Nov 10, 2016 as application 15/348,107 · Granted Dec 26, 2017
Base term, 20 years from filing
Today
20 years from filing
2009 2029
Clock starts
Apr 3, 2009
Term ends
Apr 3, 2029
Granted
Dec 26, 2017
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,252,947, US 9,877,972, to Apr 3, 2029. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 3, 2009, when application 12/418,559, the earliest non-provisional in its chain, was filed (this one was filed Nov 10, 2016)Apr 3, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,252,947, US 9,877,972)resolves to Apr 3, 2029, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 3, 2029High confidence

This family

US 8,252,947In force
Apr 2030
Apr 2030
Application 13/563,996Abandoned
not computed
not computed
Application 13/563,982Abandoned
not computed
not computed
US 9,877,972In force
Apr 2029
Apr 2029
US 9,555,046In force
Apr 2029
Apr 2029
US 9,850,271this patent
Apr 2029
Apr 2029
Application 15/851,523Abandoned
not computed
not computed
US 10,995,112In force
Apr 2029
Apr 2029
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 10, 2016
Reel 40277, frame 111
White, Steven K; Ivanisevic, Igor; Stephens, Kyle; Andres, Mark; Wolfe, Brenton SkylarHollis-Eden Pharmaceuticals, Inc.Assignment of Assignor's Interest
Nov 10, 2016
Reel 40277, frame 245
Hollis-Eden Pharmaceuticals, Inc.Harbor Biosciences, Inc.Change of Name
Nov 10, 2016
Reel 40277, frame 377
Harbor Biosciences, Inc.; Harbor Diversified, Inc.Harbor Diversified, Inc.Merger and Change of Name
Nov 10, 2016
Reel 40277, frame 437
Harbor Diversified, Inc.Harbor Therapeutics, Inc.Assignment of Assignor's Interest
Nov 10, 2016
Reel 40587, frame 268
Harbor Therapeutics, Inc.Reserva LLCAssignment of Assignor's Interest
Nov 10, 2016
Reel 40587, frame 329
Reserva LLCNeurmedix, Inc.Assignment of Assignor's Interest
Aug 9, 2021
Reel 57123, frame 760
Neurmedix, Inc.Neurmedix, LLCAssignment of Assignor's Interest
Aug 9, 2021
Reel 57123, frame 872
Neurmedix, Inc.Biovie Inc.Assignment of Assignor's Interest
Aug 9, 2021
Reel 57125, frame 46
Neurmedix, LLCNeurmedix, Inc.Assignment of Assignor's Interest
Dec 7, 2021
Reel 58329, frame 389
Biovie Inc.Avenue Venture Opportunities Fund, L.P.Security Interest
Dec 6, 2024
Reel 69510, frame 814
Avenue Venture Opportunities Fund, L.P.Biovie Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited